
Izvēlieties etiķeti
redzama tieši uz flakonaCabergoline
PCT & AI
- Sūtām no Vācijas
Pasūtījums
- DHL ar izsekošanu
- Diskrēts iepakojums
4.6 no 5 Trustpilot73 atsauksmes
Meklēts arī kā: Cabergolin
Īsumā
Cabergoline skaitļos
Galvenie rādītāji no mūsu leksikona. Velciet punktu pa līkni, lai redzētu, cik daudz paliek pēc vienas devas, pēc aprēķina.
Pilns leksikona ierakstsHow long does it stay in the body?
Share left after one dose, calculated with a half-life of ~2.9 days
Simplified model without an absorption phase, half-life from the TPD lexicon.
Half-life
about70hours
- Class
- Dopamine D2 receptor agonist
- Use
- Oral1-2x per week
- Sizes
- 0.25 to 0.5 mg2 sizes in the shop
What studies show
All 3 sources in the lexicon- Webster et al., NEJM, 1994
- Pascal-Vigneron et al., Presse Med, 1995
- DailyMed, U.S. National Library of Medicine
Produktam Cabergoline vēl nav laboratorijas analīzes. Balsot par toPasūtiet testu, mēs apmaksājam pusiVisas laboratorijas analīzes
Zināšanas
Viss par Cabergoline
Detalizēta informācija drīzumā.
How does cabergoline lower prolactin?
Cabergoline binds as an agonist to the dopamine D2 receptor. Dopamine is the natural brake on the prolactin cells in the pituitary. According to the label it has only low affinity for other receptors such as D1, alpha adrenoceptors and serotonin receptors.
Is cabergoline approved?
Yes. ChEMBL lists cabergoline as an approved compound with first approval in 1996. On ClinicalTrials.gov 83 trials list cabergoline (as of 26 October 2026). Everything here is the state of research, not a recommendation.
Is it better than bromocriptine?
In the large comparison trial with 459 women yes: prolactin was stably normal in 83 instead of 59 percent, 72 instead of 52 percent ovulated or became pregnant. Side effects occurred in 68 instead of 78 percent, 3 instead of 12 percent stopped. A French trial with 120 women came to the same result.
What about the heart valves?
The label requires a heart ultrasound before starting and checks every 6 to 12 months. Valve changes occurred mostly at high doses in Parkinson's treatment, but there are also cases at lower doses. In a cohort study in Parkinson's the rate was 68 per 10,000 person-years, with other drugs 10 to 11.
Why dizziness on standing?
Cabergoline can lower blood pressure, especially when standing up quickly. In the placebo-controlled trial 15 percent had dizziness and 4 percent a drop in blood pressure on standing, 5 and 0 percent on placebo. The label advises checking blood pressure at the start and during use.
Can cabergoline affect behaviour?
Yes, the label lists impulse control disorders: new or stronger urges to gamble, increased sexual urges, uncontrolled spending and binge eating. Anyone noticing this should raise it with a doctor.
Which trials are running right now?
As of 26 October 2026 recruiting trials include a phase 3 trial with 382 planned participants against bromocriptine, a phase 3 trial on the safety of a higher dose in microprolactinomas and a phase 4 trial on metabolism in prolactinomas.
Saistītie
Saistītie produkti
Clomid (Clomifen)
Medikamenti · Pēckursa terapija un aromatāzes inhibitori Pēckursa terapija un aromatāzes inhibitori
2 izmēri
Tamoxifen (Nolvadex)
Medikamenti · Pēckursa terapija un aromatāzes inhibitori Pēckursa terapija un aromatāzes inhibitori
2 izmēri
Laboratorijā pārbaudīts
Aromasin (Exemestane)
Medikamenti · Pēckursa terapija un aromatāzes inhibitori Pēckursa terapija un aromatāzes inhibitori
2 izmēri
Arimidex (Anastrozole)
Medikamenti · Pēckursa terapija un aromatāzes inhibitori Pēckursa terapija un aromatāzes inhibitori
2 izmēri
Cabergoline